Phase Separation Enhanced PROTAC for Highly Efficient Protein Degradation

被引:1
|
作者
Yu, Xiaolin [1 ]
Hu, Wenrui [1 ]
Dong, Hang [1 ]
Zhao, Tian [1 ]
Wang, Xiaotian [1 ]
Chen, Long [1 ]
Xue, Song [1 ]
Li, Jin-Ping [2 ,3 ]
Luo, Shi-Zhong [1 ]
机构
[1] Beijing Univ Chem Technol, Coll Life Sci & Technol, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China
[2] Beijing Univ Chem Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, Beijing 100029, Peoples R China
[3] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden
基金
中国国家自然科学基金;
关键词
TRANSITIONS; MODALITY; TARGET;
D O I
10.1021/acs.biomac.4c00424
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Biomacromolecular condensates formed via phase separation establish compartments for the enrichment of specific compositions, which is also used as a biological tool to enhance molecule condensation, thereby increasing the efficiency of biological processes. Proteolysis-targeting chimeras (PROTACs) have been developed as powerful tools for targeted protein degradation in cells, offering a promising approach for therapies for different diseases. Herein, we introduce an intrinsically disordered region in the PROTAC (denoted PSETAC), which led to the formation of droplets of target proteins in the cells and increased degradation efficiency compared with PROTAC without phase separation. Further, using a nucleus targeting intrinsically disordered domain, the PSETAC was able to target and degrade nuclear-located proteins. Finally, we demonstrated intracellular delivery of PSETAC using lipid nanoparticle-encapsulated mRNA (mRNA-LNP) for the degradation of the endogenous target protein. This study established the PSETAC mRNA-LNP method as a potentially translatable, safe therapeutic strategy for the development of clinical applications based on PROTAC.
引用
收藏
页码:4374 / 4383
页数:10
相关论文
共 50 条
  • [41] Identification of a novel Azaspirooxindolinone-based PROTAC for selective BTK degradation and enhanced anticancer activity
    Rampeesa, Naveen Kumar
    Gundla, Rambabu
    Mudasani, Gopal
    Tangallapalli, Sudhakar
    Anugu, Sreenivasa Reddy
    Gurska, Sona
    De Sanctis, Juan Bautista
    Dzubak, Petr
    Hajduch, Marian
    Das, Viswanath
    BIOORGANIC CHEMISTRY, 2025, 157
  • [42] G4-PROTAC: targeted degradation of a G-quadruplex binding protein
    Patil, Kiran M.
    Chin, Danielle
    Seah, Hui Ling
    Shi, Qi
    Lim, Kah Wai
    Anh Tuan Phan
    CHEMICAL COMMUNICATIONS, 2021, 57 (95) : 12816 - 12819
  • [43] Biosynthesis of Highly Stable Silver Nanoparticles for Enhanced Antibacterial Effect and Efficient Photocatalytic for Dye Degradation
    Ghosh, Tatan
    Chattopadhyay, Amarnath
    Pramanik, Subhamay
    Das, Sandip
    Mukherjee, Sumit
    Mandal, Atis C.
    Kuiri, Probodh K.
    BRAZILIAN JOURNAL OF PHYSICS, 2024, 54 (01)
  • [44] Biosynthesis of Highly Stable Silver Nanoparticles for Enhanced Antibacterial Effect and Efficient Photocatalytic for Dye Degradation
    Tatan Ghosh
    Amarnath Chattopadhyay
    Subhamay Pramanik
    Sandip Das
    Sumit Mukherjee
    Atis C. Mandal
    Probodh K. Kuiri
    Brazilian Journal of Physics, 2024, 54
  • [45] Accelerating PROTAC drug discovery: Establishing a relationship between ubiquitination and target protein degradation
    Gross, Patrick H.
    Sheets, Katie J.
    Warren, Noel A.
    Ghosh, Saptarshi
    Varghese, Rebekah E.
    Wass, Katherine E.
    Kadimisetty, Karteek
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 628 : 68 - 75
  • [46] Versatile Nano-PROTAC-Induced Epigenetic Reader Degradation for Efficient Lung Cancer Therapy
    Zhang, Huan-Tian
    Peng, Rui
    Chen, Sheng
    Shen, Ao
    Zhao, Lixin
    Tang, Wang
    Wang, Xiao-He
    Li, Zhen-Yan
    Zha, Zhen-Gang
    Yi, Mengmeng
    Zhang, Lingmin
    ADVANCED SCIENCE, 2022, 9 (29)
  • [47] Predicting protein degradation through computational modeling of PROTAC-mediated ternary complexes
    Drummond, Michael
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [48] ClickRNA-PROTAC for Tumor-Selective Protein Degradation and Targeted Cancer Therapy
    Teng, Xucong
    Zhao, Xuan
    Dai, Yicong
    Zhang, Xiangdong
    Zhang, Qiushuang
    Wu, Yuncong
    Hu, Difei
    Li, Jinghong
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2024, 146 (40) : 27382 - 27391
  • [49] Blocking Non-enzymatic Functions by PROTAC-Mediated Targeted Protein Degradation
    Sun, Donghuan
    Zhang, Jing
    Dong, Guoqiang
    He, Shipeng
    Sheng, Chunquan
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (21) : 14276 - 14288
  • [50] The impact of E3 ligase choice on PROTAC effectiveness in protein kinase degradation
    Sobierajski, Tomasz
    Malolepsza, Joanna
    Pichlak, Marta
    Gendaszewska-Darmach, Edyta
    Blazewska, Katarzyna M.
    DRUG DISCOVERY TODAY, 2024, 29 (07)